Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Monday, March 31, 2014

Otsuka Acquires Rights to Hematological Cancer Treatment Dacogen from Eisai

Otsuka has acquired rights from Eisai Inc. to develop and sell in the US, Canada and Japan the DNA methylation inhibitor Dacogen A .

http://ift.tt/1rWsjNN

No comments:

Post a Comment

Popular Stem Cell Roundup Posts